GLN-DIMETHYL FUMARATE

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: 8b339cd6f24701a5
Drug Approval Canada Name: GLN-DIMETHYL FUMARATE
Product Name: GLN-DIMETHYL FUMARATE
Status: Marketed
Status Date: 2021-10-19
Original Market Date: 2021-10-19
Din: 02494809
Drug Class: Human
Dosage Form: Capsule (Delayed Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 92:20.00
Atc Original: L04AX07 DIMETHYL FUMARATE
Atc Name: l 04 ax 07
Aig Number: 0154210001
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

DIMETHYL FUMARATE

120 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8b339cd6f24701a5

Type

Standard